Hot Off the Press: "May Cause Heart Attack" Added to GSK's Avandia Label
The FDA ruled today that GlaxoSmithKline’s blockbuster diabetes drug Avandia will now carry as part of its label a warning advising that its use might raise the risk of suffering a heart attack. A black box warning is the sternest warning a drug can carry and still remain on the market in the U.S. Avandia already carries a black box warning advising it could cause or exacerbate congestive heart failure in some patients.
With 2006 sales of almost $3 billion, Avandia has been a major revenue driver for Glaxo.
Look for continued corporate right sizing at GSK through 2008.
Until next time….
Good Luck and Good Job Hunting!!!!!!!!
